BDNF Val66Met 基因多态性与卒中后失语症康复的关系
该研究纳入53例卒中后失语症住院康复患者,均接受言语语言治疗,按BDNF Val66Met SNP分为携带者(至少一个Met等位基因)与非携带者。以ANELT和BNT改善评分为主要结局,结果显示两组改善评分变异大但无显著差异,不支持该多态性降低失语症语言康复效果。
要点
- BDNF Val66Met不影响卒中后失语症患者ANELT与BNT的康复改善。
- 该结果与既往报道该多态性降低运动功能康复的结论不同。
- 失语症康复结局个体差异大,基因分型未显示组间显著差异。
核心结论
- BDNF Val66Met多态性携带者与非携带者卒中后失语症的语言康复改善无显著差异。
- 本研究不支持该多态性降低卒中后失语症语言康复效果的假设。
研究设计与样本
- 纳入53例卒中后失语症患者,均参加住院康复项目并接受言语语言治疗。
- 所有患者进行Val66Met SNP基因分型,分为携带者(至少一个Met等位基因)与非携带者(无Met等位基因)。
主要发现
- ANELT和BNT的改善评分均显示较大变异。
- 非携带者与携带者在主要结局指标上无显著差异。
关键数值与推荐
- 主要结局为康复期间ANELT和BNT的改善评分。
- 基因分型依据Val66Met(rs6265)单核苷酸多态性,携带者定义含至少一个Met等位基因。
临床怎么用
- 目前证据不支持依据BDNF Val66Met基因型预测卒中后失语症的语言康复预后。
- 卒中后失语症康复应注重个体化言语语言治疗,而非基因分型指导。
局限性
- 样本量较小(53例),可能影响统计效能。
- 仅纳入住院康复患者,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Brain-derived neurotrophic factor (BDNF) is assumed to play a role in mediating neuroplasticity after stroke. Carriers of the function-limiting Val66Met (rs6265) single nucleotide polymorphism (SNP) may have a downregulation in BDNF secretion, which may lead to a poorer prognosis after stroke compared to noncarriers in motor learning and motor function recovery. The present study investigates whether this polymorphism may also affect the recovery of poststroke aphasia (ie, language impairment). OBJECTIVE: To study the influence of the BDNF Val66Met polymorphism on the recovery of poststroke aphasia. METHODS: We included 53 patients with poststroke aphasia, all participating in an inpatient rehabilitation program with speech and language therapy. All patients were genotyped for the Val66Met SNP and subdivided into carriers (at least one Met allele) and noncarriers (no Met allele). Primary outcome measures included the improvement over rehabilitation time on the Amsterdam-Nijmegen Everyday Language Test (ANELT) and the Boston Naming Test (BNT). RESULTS: The outcome measures showed a large variability in the improvement scores on both the ANELT and BNT. There was no significant difference between noncarriers and carriers in the primary outcome measures. CONCLUSION: This study investigated the effect of the BDNF Val66Met polymorphism on clinical recovery of poststroke aphasia. In contrast to earlier studies describing a reducing effect of this polymorphism on motor function recovery after stroke, the present study does not support a reduction in language recovery for carriers compared to noncarriers with poststroke aphasia.
引用
- de Boer RGA, Spielmann K, Heijenbrok-Kal MH, et al. The Role of the BDNF Val66Met Polymorphism in Recovery of Aphasia After Stroke. Neurorehabil Neural Repair. 2017. PMID: 28818006. doi:10.1177/1545968317723752
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。